Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (2725)	1/25/2011 5:31:21 PM
From: IRWIN JAMES FRANKEL	Read Replies (2) of 3027

>>Turning to a valuation issue - if you were to assume Teva gets approval say 4 months from now (which is likely best case for them), about how much cash per share would MNTA have at that point? I left my model at home (on vaca in naples FL) so this is from memory. Cash EOY $230M (including offering and AR due 45d from EOY) Cash accrual $75M (5 months at $15M) TotaL Cash $305 ~50M shares so ~$6ps ij

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next